Detection of Non-Alcoholic Fatty Liver Disease with Non-invasive Tools in Turkish People Living with HIV and with Apparently Normal Liver Function

被引:3
作者
Basaran, Nursel Calik [1 ]
Idilman, Ilkay [2 ]
Tokucoglu, Hayriye Altunay [3 ]
Onur, Mehmet Ruhi [2 ]
Sonmezer, Meliha Cagla [3 ]
Ozisik, Lale [1 ]
Karcaaltincaba, Musturay [2 ]
Inkaya, Ahmet Cagkan [3 ]
Unal, Serhat [3 ]
机构
[1] Hacettepe Univ, Med Fac, Internal Med Dept, Div Gen Internal Med, Ankara, Turkiye
[2] Hacettepe Univ, Med Fac, Dept Radiol, Ankara, Turkiye
[3] Hacettepe Univ, Med Fac, Infect Dis & Clin Microbiol Dept, Ankara, Turkiye
关键词
HIV; PLWH; fatty liver; NAFLD; liver fibrosis; MR elastography; US elastography; HEPATIC-FIBROSIS; ELASTOGRAPHY; PREVALENCE; ADULTS; ULTRASOUND; STEATOSIS;
D O I
10.2174/1570162X21666230714122716
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Non-alcoholic fatty liver disease (NAFLD) has become a significant cause of mortality and morbidity in people living with HIV.Objective: We aimed to investigate NAFLD presence by magnetic resonance imaging (MRI) methods, including MRI-derived proton density fat fraction (MRI-PDFF) and MRE, and ultrasound elastography among Turkish people living with HIV (PLWH), and identify factors correlated with fatty liver.Methods: We included 57 PLWH attending outpatient clinics on antiretroviral therapy (ART) for more than six months, without HBV/HCV co-infection, significant alcohol consumption, active opportunistic infection, previously diagnosed hepatobiliary disease, T2DM, and hyperlipidemia. We performed MRI, MRE, and US elastography on all participants.Results: The mean age of the participants (M/F, 47/10) was 41.7 +/- 12 years. The median duration of HIV infection was 3 (0.5-19 years) years. The mean MRI-PDFF was 4.4 +/- 3.8%, and 11 had fatty liver. The mean MRE value was 2.27 +/- 0.6 kPa, inflammation was present in 16, and 4 participants had values consistent with fibrosis. The mean US elastography of the study population was 4.1 +/- 2.4 kPa. The mean right and left CCA intima-media of the study population was 0.65 +/- 0.23 mm and 0.66 +/- 0.25 mm; 16 had increased intima-media thickness. In patients with fatty liver, a significant positive correlation was present between MRE and CCA intima-media thickness (rs=0.82, p:0.006 for MRE-left CCA; r=0.68, p=0.042 for MRE-right CCA).Conclusion: We demonstrated that even a significant proportion of PLWH individuals with normal transaminase levels have fatty liver. Future prospective trials are warranted to understand and mitigate the risk factors, course of NAFLD, and accurate non-invasive tests, predicting fibrosis in people living with HIV.
引用
收藏
页码:192 / 201
页数:10
相关论文
共 32 条
[21]   Prevalence and predictors of liver steatosis and fibrosis in unselected patients with HIV mono-infection [J].
Lombardi, Rosa ;
Sambatakou, Helen ;
Mariolis, Ilias ;
Cokkinos, Demosthenis ;
Papatheodoridis, George V. ;
Tsochatzis, Emmanuel A. .
DIGESTIVE AND LIVER DISEASE, 2016, 48 (12) :1471-1477
[22]   Prevalence and risk factors of nonalcoholic fatty liver disease in HIV-monoinfection [J].
Maurice, James B. ;
Patel, Amee ;
Scott, Alasdair J. ;
Patel, Krish ;
Thursz, Mark ;
Lemoine, Maud .
AIDS, 2017, 31 (11) :1621-1632
[23]   Transient elastography for the detection of hepatic fibrosis in HIV-monoinfected adults with elevated aminotransferases on antiretroviral therapy [J].
Morse, Caryn G. ;
McLaughlin, Mary ;
Proschan, Michael ;
Koh, Christopher ;
Kleiner, David E. ;
Heller, Theo ;
Kovacs, Joseph A. .
AIDS, 2015, 29 (17) :2297-2302
[24]   Nonalcoholic Steatohepatitis and Hepatic Fibrosis in HIV-1-Monoinfected Adults With Elevated Aminotransferase Levels on Antiretroviral Therapy [J].
Morse, Caryn G. ;
McLaughlin, Mary ;
Matthews, Lindsay ;
Proschan, Michael ;
Thomas, Francine ;
Gharib, Ahmed M. ;
Abu-Asab, Mones ;
Orenstein, Abigail ;
Engle, Ronald E. ;
Hu, Xiaojun ;
Lempicki, Richard ;
Hadigan, Colleen ;
Kleiner, David E. ;
Heller, Theo ;
Kovacs, Joseph A. .
CLINICAL INFECTIOUS DISEASES, 2015, 60 (10) :1569-1578
[25]   A position statement on NAFLD/NASH based on the EASL 2009 special conference [J].
Ratziu, Vlad ;
Bellentani, Stefano ;
Cortez-Pinto, Helena ;
Day, Chris ;
Marchesini, Giulio .
JOURNAL OF HEPATOLOGY, 2010, 53 (02) :372-384
[26]   Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis. [J].
Sanyal, Arun J. ;
Chalasani, Naga ;
Kowdley, Kris V. ;
McCullough, Arthur ;
Diehl, Anna Mae ;
Bass, Nathan M. ;
Neuschwander-Tetri, Brent A. ;
Lavine, Joel E. ;
Tonascia, James ;
Unalp, Aynur ;
Van Natta, Mark ;
Clark, Jeanne ;
Brunt, Elizabeth M. ;
Kleiner, David E. ;
Hoofnagle, Jay H. ;
Robuck, Patricia R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (18) :1675-1685
[27]   Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration [J].
Smith, Colette J. ;
Ryom, Lene ;
Weber, Rainer ;
Morlat, Philippe ;
Pradier, Christian ;
Reiss, Peter ;
Kowalska, Justyna D. ;
de Wit, Stephane ;
Law, Matthew ;
el Sadr, Wafaa ;
Kirk, Ole ;
Friis-Moller, Nina ;
Monforte, Antonella d'Arminio ;
Phillips, Andrew N. ;
Sabin, Caroline A. ;
Lundgren, Jens D. .
LANCET, 2014, 384 (9939) :241-248
[28]   Hepatic steatosis and antiretroviral drug use among adults coinfected with HIV and hepatitis C virus [J].
Sulkowski, MS ;
Mehta, SH ;
Torbenson, M ;
Afdhal, NH ;
Mirel, L ;
Moore, RD ;
Thomas, DL .
AIDS, 2005, 19 (06) :585-592
[29]  
VanWagner Lisa B, 2016, Curr Hepatol Rep, V15, P75
[30]   Clinical, biochemical and histological differences between HIV-associated NAFLD and primary NAFLD: a case-control study [J].
Vodkin, I. ;
Valasek, M. A. ;
Bettencourt, R. ;
Cachay, E. ;
Loomba, R. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 41 (04) :368-378